$51.9M Presale Dominates Over VeChain Partnership and INJ Price Swings
Injective (INJ) is currently battling market uncertainties, with analysts cautioning that a breach below the $19.30 mark could lead to severe losses. Concurrently, VeChain has entered into a promising partnership to redefine health and wellness […]
